Stereotaxis receives FDA approval for robotic ablation catheter
Tweet Send to a Friend
Stereotaxis (NYSE: STXS) announced it received U.S. Food and Drug Administration approval for its MAGiC Magnetic Interventional Ablation Catheter on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


